Cargando…

Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Hu, Chen, Zou, Fengming, Wang, Aoli, Miao, Weili, Liang, Qianmao, Weisberg, Ellen L., Wang, Yinsheng, Liu, Jing, Wang, Wenchao, Liu, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440619/
https://www.ncbi.nlm.nih.gov/pubmed/34521806
http://dx.doi.org/10.1038/s41392-021-00672-7
_version_ 1783752714697572352
author Hu, Chen
Zou, Fengming
Wang, Aoli
Miao, Weili
Liang, Qianmao
Weisberg, Ellen L.
Wang, Yinsheng
Liu, Jing
Wang, Wenchao
Liu, Qingsong
author_facet Hu, Chen
Zou, Fengming
Wang, Aoli
Miao, Weili
Liang, Qianmao
Weisberg, Ellen L.
Wang, Yinsheng
Liu, Jing
Wang, Wenchao
Liu, Qingsong
author_sort Hu, Chen
collection PubMed
description
format Online
Article
Text
id pubmed-8440619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84406192021-10-04 Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia Hu, Chen Zou, Fengming Wang, Aoli Miao, Weili Liang, Qianmao Weisberg, Ellen L. Wang, Yinsheng Liu, Jing Wang, Wenchao Liu, Qingsong Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-09-15 /pmc/articles/PMC8440619/ /pubmed/34521806 http://dx.doi.org/10.1038/s41392-021-00672-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Hu, Chen
Zou, Fengming
Wang, Aoli
Miao, Weili
Liang, Qianmao
Weisberg, Ellen L.
Wang, Yinsheng
Liu, Jing
Wang, Wenchao
Liu, Qingsong
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title_full Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title_fullStr Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title_full_unstemmed Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title_short Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
title_sort targeting chaperon protein hsp70 as a novel therapeutic strategy for flt3-itd-positive acute myeloid leukemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440619/
https://www.ncbi.nlm.nih.gov/pubmed/34521806
http://dx.doi.org/10.1038/s41392-021-00672-7
work_keys_str_mv AT huchen targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT zoufengming targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT wangaoli targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT miaoweili targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT liangqianmao targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT weisbergellenl targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT wangyinsheng targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT liujing targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT wangwenchao targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia
AT liuqingsong targetingchaperonproteinhsp70asanoveltherapeuticstrategyforflt3itdpositiveacutemyeloidleukemia